SCHEMBL9545127

SCHEMBL9545127

CC(C)(C)OC(=O)N(CCc1ccc(OCC(=O)O)cc1)CC(O)c1cccc(C(F)(F)F)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTB4R2 Q9NPC1 1/20 0.44
FFAR1 O14842 1/20 0.43
FFAR4 Q5NUL3 1/20 0.43
RXRA P19793 3/20 0.43
NR1H2 P55055 3/20 0.43
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA4 P22748 1/20 0.42
CA9 Q16790 1/20 0.42
ADRB1 P08588 5/20 0.42
NR1H3 Q13133 1/20 0.42
ADRB3 P13945 7/20 0.41
BACE1 P56817 3/20 0.41
ADRB2 P07550 1/20 0.40
ADRA1D P25100 1/20 0.40
ADRA1A P35348 1/20 0.40
ADRA1B P35368 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9545094 0.87 ADRB3 (0.43) FFAR1FFAR4RXRANR1H2ADRB3
SCHEMBL4468296 0.85 ADRB3 (0.59) ADRB1ADRB3ADRB2ADRA1DADRA1A
SCHEMBL4462538 0.85 ADRB3 (0.60) ADRB1ADRB3BACE1ADRB2ADRA1D
SCHEMBL4468301 0.85 ADRB3 (0.59) ADRB1ADRB3ADRB2ADRA1DADRA1A
SCHEMBL4479032 0.85 ADRB3 (0.60) ADRB1ADRB3ADRB2ADRA1DADRA1A
SCHEMBL4462534 0.85 ADRB3 (0.60) ADRB1ADRB3BACE1ADRB2ADRA1D
SCHEMBL4462017 0.84 ADRB3 (0.61) ADRB1ADRB3ADRB2ADRA1DADRA1A
SCHEMBL4462013 0.84 ADRB3 (0.61) ADRB1ADRB3ADRB2ADRA1DADRA1A
SCHEMBL4465633 0.83 ADRB1 (0.63) ADRB1ADRB3BACE1ADRB2ADRA1D
SCHEMBL5669215 0.83 ADRB3 (0.61) ADRB1ADRB3BACE1ADRB2ADRA1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1993010074-A1 ARYLETHANOLAMINE DERIVATIVES AND THEIR USE AS BETA-3-ADRENOCEPTOR AGONISTS SMITHKLINE BEECHAM PLC (GB) 1993-05-27 WO disclosed